CD79b peptide TLKDGIIMI (HLA-A*0201)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
CD79b peptide TLKDGIIMI (HLA-A*0201)

CD79b(52-60) peptide TLKDGIIMI (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from CD79b is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: TLKDGIIMI
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: HLA-A*0201

Podobne produkty

SARS-CoV-2 peptide GYQPYRVVVL (HLA-A*2402)

SARS-CoV-2 peptide GYQPYRVVVL (HLA-A*2402)

IBA Lifescience
Więcej
HIV Gag peptide SLYNTVATL (HLA-A*0201)

HIV Gag peptide SLYNTVATL (HLA-A*0201)

IBA Lifescience
Więcej
ADV E1A peptide LLDQLIEEV (HLA-A*0201)

ADV E1A peptide LLDQLIEEV (HLA-A*0201)

IBA Lifescience
Więcej